Charts
|
CHN |
Re:
CHN chart
|
|
lima88
|
8.5K |
3.6M |
8 |
08/05/24 |
08/05/24 |
Charts
|
8.5K
|
3.6M
|
8
|
|
ASX - By Stock
|
AGN |
Re:
AGN Media thread
|
|
lima88
|
94 |
34K |
2 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
94
|
34K
|
2
|
|
ASX - By Stock
|
AGN |
Re:
AGN Media thread
|
|
lima88
|
94 |
34K |
4 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
94
|
34K
|
4
|
|
Charts
|
CHN |
Re:
CHN chart
|
|
lima88
|
8.5K |
3.6M |
4 |
10/04/24 |
10/04/24 |
Charts
|
8.5K
|
3.6M
|
4
|
|
Charts
|
CHN |
Re:
CHN chart
|
|
lima88
|
8.5K |
3.6M |
2 |
07/04/24 |
07/04/24 |
Charts
|
8.5K
|
3.6M
|
2
|
|
Charts
|
CHN |
Re:
CHN chart
|
|
lima88
|
8.5K |
3.6M |
8 |
04/04/24 |
04/04/24 |
Charts
|
8.5K
|
3.6M
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
lima88
|
63 |
20K |
3 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
63
|
20K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Mainstream media is GO
|
|
lima88
|
31 |
11K |
8 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
31
|
11K
|
8
|
|
ASX - By Stock
|
AGN |
Re:
Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007
|
|
lima88
|
49 |
15K |
0 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
49
|
15K
|
0
|
|
ASX - By Stock
|
AGN |
Re:
Ann: FDA Grants Rare Pediatric Disease Designation For HIE
|
|
lima88
|
18 |
5.4K |
8 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
18
|
5.4K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
lima88
|
222 |
49K |
5 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
222
|
49K
|
5
|
|
Charts
|
CHN |
Re:
CHN chart
|
|
lima88
|
8.5K |
3.6M |
2 |
15/03/24 |
15/03/24 |
Charts
|
8.5K
|
3.6M
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
lima88
|
100 |
28K |
18 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
100
|
28K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
lima88
|
100 |
28K |
16 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
100
|
28K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
lima88
|
1.4K |
366K |
4 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
1.4K
|
366K
|
4
|
|
ASX - By Stock
|
SGA |
Re:
Ann: Five Nines Graphite Purity Exceeded
|
|
lima88
|
115 |
29K |
1 |
10/03/24 |
10/03/24 |
ASX - By Stock
|
115
|
29K
|
1
|
|
ASX - By Stock
|
1AD |
Re:
Ann: Corporate Presentation
|
|
lima88
|
118 |
25K |
1 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
118
|
25K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
lima88
|
1.4K |
366K |
18 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
1.4K
|
366K
|
18
|
|
ASX - By Stock
|
1AD |
Re:
Ann: Positive AD-214 Phase I extension study results
|
|
lima88
|
262 |
55K |
1 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
262
|
55K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
lima88
|
317 |
83K |
5 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
317
|
83K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
lima88
|
317 |
83K |
11 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
317
|
83K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
lima88
|
317 |
83K |
19 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
317
|
83K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
lima88
|
152 |
47K |
6 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
152
|
47K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
lima88
|
152 |
47K |
23 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
152
|
47K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
lima88
|
209 |
51K |
25 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
209
|
51K
|
25
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
lima88
|
1.4K |
366K |
12 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
1.4K
|
366K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
lima88
|
1.4K |
366K |
28 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
1.4K
|
366K
|
28
|
|
ASX - By Stock
|
PAA |
Re:
Ann: EGM Shareholder Presentation
|
|
lima88
|
45 |
13K |
28 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
45
|
13K
|
28
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
lima88
|
1.4K |
366K |
6 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
1.4K
|
366K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Pause in Trading
|
|
lima88
|
45 |
25K |
10 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
45
|
25K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Outlines Pathway to Accelerated Approval for MPL in MND
|
|
lima88
|
58 |
16K |
9 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
58
|
16K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
lima88
|
197 |
54K |
8 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
197
|
54K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
lima88
|
197 |
54K |
10 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
197
|
54K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
lima88
|
197 |
54K |
19 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
197
|
54K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Ethics Committee Approval for Open-Label MND Extension Study
|
|
lima88
|
23 |
7.2K |
14 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
23
|
7.2K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
lima88
|
1.3K |
555K |
8 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
1.3K
|
555K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
lima88
|
3.4K |
1.2M |
6 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
lima88
|
10K |
3.0M |
3 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
10K
|
3.0M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
lima88
|
3.4K |
1.2M |
2 |
02/07/23 |
02/07/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
lima88
|
13K |
5.0M |
1 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
13K
|
5.0M
|
1
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: Zip Announces Partnership with Ebay, Launches Zip Business
|
|
lima88
|
190 |
101K |
1 |
26/08/20 |
26/08/20 |
ASX - By Stock
|
190
|
101K
|
1
|
|
Charts
|
ZIP |
Re:
$9 party
|
|
lima88
|
170 |
77K |
2 |
26/08/20 |
26/08/20 |
Charts
|
170
|
77K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
lima88
|
2.3K |
905K |
2 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
2.3K
|
905K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
lima88
|
2.3K |
905K |
1 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
2.3K
|
905K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Countdown to Interim Analysis
|
|
lima88
|
195 |
71K |
0 |
15/07/20 |
15/07/20 |
ASX - By Stock
|
195
|
71K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Pick the Closing Price after FDA approval on that day
|
|
lima88
|
449 |
190K |
1 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
449
|
190K
|
1
|
|